Press Releases

AMA: Trump administration requiring pricing information in TV drug ads

| 2 Min Read

Statement attributable to:

Barbara L. McAneny, MD 

President, American Medical Association

“The Trump Administration has taken a step in the right direction by requiring pricing information in direct-to-consumer television advertising of prescription drugs. Last year, the AMA called for regulations requiring the ads to include the manufacturer’s list price of those drugs, and we have supported similar legislative efforts. This small dose of transparency will help patients have a more complete picture when faced with prescription drug ads. 

 

Full press statement available when you sign in

Sign in to the AMA website to get the full version of this press statement. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Pharmacist speaks with customer

Physician-led care is best prescription for health of nation

| 5 Min Read
Reviewing data on a laptop

Turning data into action to strengthen physician well-being

| 7 Min Read
Doctor raising hand to ask a question in a seminar

Building physician leaders who guide with heart and skill

| 7 Min Read
Hand signing a contract

What doctors wish patients knew about end-of-life care planning

| 6 Min Read